Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. coordinators
  5. netherlands
  6. academisch ziekenhuis leiden

Horizon2020 projects coordinated by "ACADEMISCH ZIEKENHUIS LEIDEN"

# project acronym  year  total cost  totalcontribution 
1 RETHRIM Restoring tissue regeneration in patients with visceral Graft versus Host Disease. 2015 5˙857˙587.00 5˙857˙587.00
2 CIRCADOPAMINE The Role of Dopamine in the Regulation of Sleep and Circadian Rhythms 2015 177˙598.00 177˙598.00
3 GLYCOCAN Exploiting Glycosylation of Colorectal Cancer for the development of improved diagnostics and therapeutics 2015 3˙297˙697.00 3˙293˙890.00
4 BRIDGES Breast Cancer Risk after Diagnostic Gene Sequencing (BRIDGES) 2015 6˙460˙000.00 6˙200˙000.00
5 FRESH AIR Free Respiratory Evaluation and Smoke-exposure reductionby primary Health cAre Integrated gRoups 2015 2˙990˙750.00 2˙990˙750.00
6 NOMA-MRI Novel materials to improve magnetic resonance imaging 2015 2˙263˙692.00 2˙263˙692.00
7 STEMCARDIORISK Stem Cells for Cardiac Arrhythmia Risk Assessment 2015 1˙500˙000.00 1˙500˙000.00
8 THYRAGE Resetting the THYRoid axis for prevention of AGE-related diseases and co-morbidities 2016 6˙000˙001.00 6˙000˙000.00
9 U-PGX Ubiquitous Pharmacogenomics (U-PGx): Making actionable pharmacogenomic data and effective treatment optimization accessible to every European citizen 2016 14˙936˙613.00 14˙936˙613.00
10 MY NERVE Translation of a fluorescent MYelin specific peripheral NERVE tracer 2016 140˙000.00 140˙000.00
11 ERCOPE The ER located master regulation of endosomal positioning and further movements 2016 2˙383˙625.00 2˙383˙625.00
12 GLYSIGN Exploitation of Glycosylation Signatures for Precision Medicine 2016 1˙552˙846.00 1˙552˙846.00
13 TIMASCAN Recirculated tissue macrophages (TiMa) in blood: Novel approach to early diagnosis and treatment monitoring in oncology 2016 2˙500˙000.00 2˙500˙000.00
14 BIO-ICD Biological auto-detection and termination of heart rhythm disturbances 2017 1˙485˙028.00 1˙485˙028.00
15 OVO-GROWTH Oogenesis spotlighted: making mature human oocytes 2017 2˙000˙000.00 2˙000˙000.00
16 AUTOCOMPLEMENT The role of complement in the induction of autoimmunity against post-translationally modified proteins 2017 1˙999˙802.00 1˙999˙802.00
17 ORCHID Organ on Chip in Development 2017 520˙472.00 520˙472.00
18 RACE Rheumatoid Arthritis Caught Early: investigating biological mechanisms preceding chronification of joint inflammation to identify patients prior to presentation of classic chronic arthritis 2017 1˙500˙000.00 1˙500˙000.00
19 BIONANOPATTERN Protein nano-patterning using DNA nanotechnology; control of surface-based immune system activation 2018 1˙499˙850.00 1˙499˙850.00
20 RECOMB Stem-cell based gene therapy for recombination deficient SCID (RECOMB) 2018 5˙990˙460.00 5˙990˙460.00
21 EPICBIOME Development of an innovative Airway-on-Chip microbiome cell culture model to investigate host-microbiome interactions at the airway epithelial surface 2018 162˙864.00 162˙864.00
22 DUX4 Function of DUX4 in skeletal muscle and non-muscle tissues 2018 177˙598.00 177˙598.00
23 MTBHLAE Investigation of a novel immune cell type in Tuberculosis: characterization of the specificity, function and pathogen killing ability of T cells restricted by non-classical HLA-E molecules 2018 165˙598.00 165˙598.00
24 EMBRACE Elucidating Mechanisms of Bladder Cancer Metastasis 2018 177˙598.00 177˙598.00
25 AUTO NERVE Tracers for targeting nerves in the autonomic nervous system 2018 140˙000.00 140˙000.00
26 CONT-END Attempts to Control the End of Life in People with Dementia: Two-level Approach to Examine Controversies 2018 1˙988˙972.00 1˙988˙972.00
27 ARTHRITISHEAL Establishing the molecular fundamentals of arthritic diseases – a step forward to Heal Arthritis 2019 3˙297˙271.00 3˙297˙271.00
28 HARMONIZATFORMS Defining the antithrombin measurand: role of proteoforms in harmonisation of diagnostic tests in thrombosis 2019 187˙572.00 187˙572.00
29 RESPIRINTM Progress novel assets (one FIH start) for non-tubercular mycobacteria that may act synergistically with bedaquiline and cytochrome bc drugs 2019 8˙060˙640.00 5˙687˙983.00
30 RESPIRITB Progress new assets (one pre-new molecular entity and one first-time-in-human start) for tuberculosis that act synergistically with bedaquiline, cytochrome bc or cytochrome bd inhibitors 2019 9˙962˙900.00 6˙840˙000.00
31 TACTIC TArgeTed molecular Imaging and surgery for gastro-intestinal Cancer 2019 150˙000.00 150˙000.00
32 DIURNALHEALTH The circadian clock in day-active species: preserving our health in modern society 2019 2˙233˙250.00 2˙233˙250.00
33 CAST Active Monitoring of Cancer As An Alternative To Surgery 2019 4˙111˙553.00 4˙111˙553.00
34 RARITY RAtional design of canceR ImmunoTherapY: one size does not fit all 2019 1˙499˙795.00 1˙499˙795.00
35 NOVA-MRI Novel Applications in 19F Magnetic Resonance Imaging 2020 4˙051˙634.00 4˙051˙634.00
36 SIGNATURE Selection of human iPSC-derived cardiomyocytes by sinGle cell geNe expression and pAtch clamp for a maTUre caRdiac modEl 2020 187˙572.00 187˙572.00
37 RISE-WELL Critical solutions for elderly well-being 2020 2˙691˙279.00 2˙691˙279.00
38 ACQUIRE Assessing cardiac Contractility and Quantification of Underlying mechanisms In vitro via Response in Excitation-contraction coupling 2020 0.00 150˙000.00

More Horizon 2020 projects

The Institution ACADEMISCH ZIEKENHUIS LEIDEN has been involved also in the following Horizon 2020 projects.